Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis
A Prospective Study of Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis
1 other identifier
observational
24
1 country
1
Brief Summary
Numerous treatment modalities have been proposed to treat pain in alcoholic and non-alcoholic chronic pancreatitis such as analgesic medication, inhibition of gastric acid production, enzyme substitution, somatostatin analogues, nerve blockade,reduction of oxidative stress and endoscopic pancreatic duct stenting, but none of these concepts have shown long lasting benefits as surgery in clinical studies.Comparison of surgical outcome in non-alcoholic chronic pancreatitis and alcoholic chronic pancreatitis has limited data and differences on the basis of outcome in between alcoholic and non-alcoholic chronic pancreatitis are not available in literature. Although it is well known that pain is the main symptom of chronic pancreatitis, it has until now been assessed in very common and varying categories. Pain, however, is only one aspect of the large variety of sensitive facets of daily life. In addition to an improvement in pain symptoms and the preservation of pancreatic exocrine and endocrine function and other parameters, occupational rehabilitation of these mostly young patients and quality of life also should be considered in the evaluation of surgical outcome in alcoholic and non-alcoholic chronic pancreatitis. In this prospective study, we intend to find out if there are any differences in the surgical outcome on the above mentioned parameters in alcoholic and non-alcoholic chronic pancreatitis.We also plan to see if there are differences in the histopathology in these two disease settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 18, 2014
CompletedFirst Posted
Study publicly available on registry
January 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedNovember 11, 2014
November 1, 2014
2.4 years
January 18, 2014
November 8, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of life
Within first 6 months from the time of surgery
Differences in extent of parenchymal fibrosis, inflammation and ductal obstruction of alcoholic and non alcoholic chronic pancreatitis
Two weeks after surgery
Secondary Outcomes (3)
Pain relief
Within first 6 months after surgery
HbA1C,Fasting insulin and C-peptide levels
Within first 6 months after surgery
Fecal elastase levels
Within first 6 months after surgery
Study Arms (2)
Alcoholic
Non alcoholic
Interventions
Duodenum preserving head resection
Eligibility Criteria
All patients of chronic pancreatitis with unremitting pain requiring surgery at primary care clinic
You may qualify if:
- Diagnosis of chronic pancreatitis confirmed by at least 2 of the following:
- Typical Chronic epigastric abdominal pain
- Elevation of serum Amylase\>3 times upper limit normal or
- Fecal elastase less than 200ug/g stool.
- Confirmatory findings on cross-sectional imaging:
- Changes in size, shape and contour of pancreas
- Dilatation of main pancreatic duct
- Calcification
- Pseudocyst
- Pancreatic duct stricture
- Patients who fulfill the criteria for surgical intervention
You may not qualify if:
- Not agreeing for surgical management
- On going acute pancreatitis
- Postop alcohol intake
- Pregnancy.
- Chronic pancreatitis with Malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Postgraduate Institute of Medical Education and Research
Chandigarh, Chandigarh, 160012, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rajesh Gupta, M.Ch.
Professor
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Additional Professor
Study Record Dates
First Submitted
January 18, 2014
First Posted
January 29, 2014
Study Start
January 1, 2012
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
November 11, 2014
Record last verified: 2014-11